Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1985 Jan;27(1):28–32. doi: 10.1128/aac.27.1.28

In vitro activity of Sch 34343 against enterococci and other gram-positive bacteria.

G M Eliopoulos, E Reiszner, R C Moellering Jr
PMCID: PMC176199  PMID: 3845792

Abstract

The in vitro activity of Sch 34343, a new penem antibiotic, was compared with those of imipenem, vancomycin, and eight other antibiotics against gram-positive bacteria. Ninety percent of methicillin-susceptible Staphylococcus aureus and penicillin-susceptible streptococcal isolates were inhibited by Sch 34343 at concentrations of less than or equal to 0.125 micrograms/ml. Listeria monocytogenes isolates were susceptible to the penem at concentrations of less than or equal to 0.25 micrograms/ml. Penicillin-resistant pneumococci and viridans streptococci were relatively resistant to Sch 34343 (MIC for 90% of the isolates, 4 micrograms/ml), as were methicillin-resistant strains of S. aureus (MIC for 90% of the isolates, greater than or equal to 256 micrograms/ml). All 48 strains of Streptococcus faecalis were inhibited by concentrations of less than or equal to 8 micrograms of the drug per ml. Combinations of Sch 34343 with gentamicin demonstrated bactericidal synergism against 5 of 10 enterococcal strains tested in broth media and against 6 of 10 strains tested in 50% pooled human serum. The serum protein binding of Sch 34343 was ca. 65%. The antibacterial activity of Sch 34343 remained stable after 24 h of incubation at 37 degrees C in water or Dextrose-Phosphate broth. However, 63% of bioassayable activity was lost after 24 h of incubation at 37 degrees C in 50% human serum buffered with HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) (pH 7.4).

Full text

PDF
28

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett J. V., Kirby W. M. A rapid, modified ultrafiltration method for determining serum protein binding and its application to new penicillins. J Lab Clin Med. 1965 Nov;66(5):721–732. [PubMed] [Google Scholar]
  2. Brown R. M., Wise R., Andrews J. M. Sch 29482--a novel penem antibiotic: an in-vitro comparison of its activity with other beta-lactams. J Antimicrob Chemother. 1982 Feb;9 (Suppl 100):17–23. doi: 10.1093/jac/9.suppl_c.17. [DOI] [PubMed] [Google Scholar]
  3. Eliopoulos G. M., Gardella A., Moellering R. C., Jr In-vitro activity of Sch 29482 in comparison with other oral antibiotics. J Antimicrob Chemother. 1982 Feb;9 (Suppl 100):143–152. doi: 10.1093/jac/9.suppl_c.143. [DOI] [PubMed] [Google Scholar]
  4. Ganguly A. K., Girijavallabhan V. M., McCombie S., Pinto P., Rizi R., Jeffrey P. D., Lin S. Synthesis of Sch 29482--a novel penem antibiotic. J Antimicrob Chemother. 1982 Feb;9 (Suppl 100):1–5. doi: 10.1093/jac/9.suppl_c.1. [DOI] [PubMed] [Google Scholar]
  5. Glew R. H., Moellering R. C., Jr Effect of protein binding on the activity of penicillins in combination with gentamicin against enterococci. Antimicrob Agents Chemother. 1979 Jan;15(1):87–92. doi: 10.1128/aac.15.1.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lincoln L. J., Weinstein A. J., Gallagher M., Abrutyn E. Penicillinase-resistant penicillins plus gentamicin in experimental enterococcal endocarditis. Antimicrob Agents Chemother. 1977 Oct;12(4):484–489. doi: 10.1128/aac.12.4.484. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES